Lymphoma

Filter By:
05:19
Recorded at the 2014 International Workshop on Non-Hodgkin Lymphoma, Dr. Owen O’Connor gives an update on brentuximab vedotin (Adcetris), an antibody drug conjugate (ADC) approved for the treatment of CD30-positive lymphomas, like anaplastic large-cell lymphoma and Hodgkin lymphoma. Dr. O’Connor exp...
by:patientpower | 198 views
07:37
Watch as Dr. Owen O’Connor gives us an overview of the state of treatment for T-Cell lymphoma and the latest news on emerging therapies. Despite a historical challenge in treating T-cell lymphomas, Dr. O’Connor is encouraged by the recent drug approvals and ongoing clinical trials into the use of histone deacetylase (HDAC) inhibitors both as single...
by:patientpower | 283 views
03:34
Novel agents emerging for the treatment of lymphoma are offering some patients the opportunity of long-term disease control while avoiding aggressive and highly toxic chemotherapy therapies. For the time being, this means changing the goal of treatment from cure to control. Can patients live well wi...
by:patientpower | 669 views
12:08
Where are we now with treatment approaches for follicular and indolent lymphomas? What is in store for the near future? How are monoclonal antibodies changing therapy today? In this video, Dr. Wyndham Wilson, from the National Cancer Institute, joins Dr. John Gribben, from the Barts Cancer Center in London, at the 2014 International Workshop on Non...
by:patientpower | 197 views
02:16
How can you tell if you might have Follicular Lymphoma (FL), a common type of indolent non-Hodgkin lymphoma (NHL). Learn the signs and symptoms from Dr. Wyndham Wilson from the National Cancer Institute (NCI). Read the transcript | http://www.p...-...
by:patientpower | 942 views
07:21
Newly approved medications are beginning to offer patients with indolent lymphomas new options for continuous disease control, while avoiding some of the side effects of traditional chemotherapy treatments. The question for many patients is whether or not these drugs might extend their lives longer ...
by:patientpower | 377 views
09:39
As chief of the lymphoma/myelom​a service at Roswell Park Cancer Institute in Buffalo, New York, Dr. Myron Czuczman, is feeling very positive about the latest developments in fighting lymphomas. In this thoughtful interview, recorded at the 2014 International Workshop on Non-Hodgkin Lymphoma (iwNHL),...
by:patientpower | 279 views
02:16
Doctors and patients alike have shown excitement over a new generation of novel agents for the treatment of non-Hodgkin lymphoma that allows some patients to take continuous, oral medications with less toxicity than traditional chemotherapy. While these drugs may offer kinder, gentler treatment path...
by:patientpower | 997 views
01:55
Patients with cancer undergoing chemotherapy and radiation may be at risk for Oral Mucositis, a condition characterized by redness, inflammation and ulcer like sores throughout the mouth and throat. Oral Mucositis can be extremely painful and may also lead to infection. The following tips can be hel...
by:DARABioSciences | 1472 views
06:52
Louis M. Weiner, MD, explains that checkpoint inhibitors represent a promising treatment option for essentially all types of cancer, since a tumor cannot form without first overcoming the immune system. To view more from this discussion, visit http://www.o...
by:onclivetv | 512 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)